Indications
ELIQUIS (apixaban) is a prescription
medicine used to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a prescription
medicine used to treat blood clots in the veins of your legs (deep vein thrombosis) or lungs (pulmonary embolism), and reduce the risk of them occurring again.
ELIQUIS (apixaban) is a prescription
medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a prescription
medicine used to reduce the risk of forming a blood clot in the legs and lungs of people who have just had hip or knee replacement surgery.
Indications
ELIQUIS (apixaban) is a
prescription medicine used in adults to reduce the risk of stroke and blood clots in people who have atrial fibrillation (AFib), a type of irregular heartbeat, not caused by a heart valve problem.
ELIQUIS (apixaban) is a
prescription medicine used in adults to treat blood clots in the veins of your legs (deep vein thrombosis-DVT) or lungs (pulmonary embolism-PE), and to reduce the risk of them occurring again after receiving treatment for blood clots.
ELIQUIS (apixaban) is a
prescription medicine used in children from birth and older to treat blood clots in the veins of legs and lungs (venous thromboembolism) after at least 5 days of initial anticoagulant treatment, and to reduce the risk of them happening again. ELIQUIS was not studied and is not recommended in children weighing less than 5.7 pounds (2.6 kg).
ELIQUIS (apixaban) is a
prescription medicine used in adults to help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of people who have just had hip or knee replacement surgery.
LOVENOX® (enoxaparin) is a blood thinner that is only available in injectable form.
Warfarin is a pill that's taken orally. Patients taking warfarin have to follow certain dietary restrictions. Warfarin also requires patients to go for routine INR blood testing to check if their levels are within the target range and to adjust their warfarin dose if they're not.
DOACs (direct-acting oral anticoagulants), including ELIQUIS, are blood thinners that can help prevent a blood clot in the veins of your legs (deep vein thrombosis-DVT) and lungs (pulmonary embolism-PE) of adults who have just had hip or knee replacement surgery. Unlike LOVENOX®, which is injected, ELIQUIS is taken by mouth twice daily. And unlike warfarin, ELIQUIS has no dietary restrictions and does not require routine INR blood testing.
LOVENOX® is a registered trademark of sanofi-aventis U.S. LLC.
Take ELIQUIS exactly as prescribed by your healthcare provider. ELIQUIS is taken by mouth twice daily. The recommended dose of ELIQUIS is 2.5 mg and the initial dose is usually taken 12 to 24 hours after surgery. If you miss a dose of ELIQUIS, take it as soon as you remember, and do not take 2 doses at the same time. If you have trouble swallowing the tablet whole, talk to your doctor about other ways to take ELIQUIS tablets.
Do not run out of ELIQUIS. Refill your prescription before you run out. When leaving the hospital following hip or knee replacement, be sure that you will have ELIQUIS available to avoid missing any doses.
Please click here for more information about how to take ELIQUIS.
Your healthcare provider will decide the duration of your treatment. The recommended dose of ELIQUIS is 2.5 mg taken by mouth twice daily. The initial dose is usually taken 12 to 24 hours after surgery.
How long ELIQUIS is taken varies from patient to patient. Your healthcare provider will decide the appropriate length of treatment for you.
ELIQUIS can cause bleeding, which can be serious, and may lead to death. This is because ELIQUIS is a blood thinner medicine that reduces blood clotting. While taking ELIQUIS, you may bruise more easily and it may take longer than usual for any bleeding to stop.
You may have a higher risk of bleeding if you take ELIQUIS and take other medicines that increase your risk of bleeding, such as:
Tell your healthcare provider if you take any of these medicines.
Call your healthcare provider or get medical help right away if you have any of these signs or symptoms of bleeding when taking ELIQUIS:
See Important Safety Information below